Merck's Gardasil 9 launches in Canada; Immunomic wins NIH grant for peanut allergy candidate;

> Merck's ($MRK) Gardasil 9 has launched in Canada. Release

> Immunomic Therapeutics has won a Small Business Innovation Research grant from the NIH for its work on a peanut allergy vaccine. Release

> Diabetes vaccine maker Diamyd Medical has received 15 million Swedish krona ($1.7 million) in a direct issue. Release

> The human vaccine market in China is slated to jump as R&D and production capacity grow. Release

And Finally... Geovax has assigned a trial number to the next study of its candidate HIV preventive. Release

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.